SynthesisInternational urology and nephrology2018

The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.

Punnaka Pongpanich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.